| 7:30-8:45 am |
Registration & Continental Breakfast |
| |
|
| 8:45-9:00 am |
Welcome & Opening Remarks
Jim Glasheen
General Partner
Technology Partners
|
| |
|
| 9:00-9:45 am |
Transition from Pharma to Consumer
Dr. Mehmood Khan is the Chief Scientific Officer of PepsiCo. He is an Endocrinologist by training and most recently was the President of Takeda Pharmaceuticals R&D. Prior to Takeda, Dr. Khan was with the Mayo Clinic as the Director of the Diabetes, Endocrine and Nutrition Clinical Trials Unit in the division of Endocrinology. Dr. Khan will speak to his personal transition from focusing on a traditional pharmaceutical business to his far more consumer facing role now and what it means for Consumer Medicine in general.
Mehmood Khan, MD
SVP, Chief Scientific Officer
PepsiCo
|
| |
|
| 9:45-10:30 am |
The Strategic Players Weigh In
Major pharmaceutical, medtech and consumer companies have been placing increasing emphasis on Consumer Medicine (CM), but what does it mean for the entrepreneurial community?
- How do strategic players view the CM landscape? What are the opportunities, what are the challenges?
- What lessons from major players should start-ups be integrating into their businesses?
- What are major companies seeking from the entrepreneurial community?
- What are the implications of a new administration?
- In the current economic environment, what areas within CM will flourish and which will flounder?
Moderator:
Steve Elms
Managing Director
Aisling Capital
Confirmed Panelists:
|
Joseph Modisett
Executive Director,
Investment Banking Division
Morgan Stanley
Karl Ronn
Vice President- Research & Development Health Care & New Business
Procter & Gamble Company
|
Adele Gulfo
Vice President, Business Development, Innovation and Design-for-Launch AstraZeneca Pharmaceuticals |
| |
|
| 10:30-11:15 am |
Networking Reception |
| |
Hosted by: |
 |
|
| |
|
| 11:15-12:00 am |
The Challenging Economy & a Shifting Healthcare Landscape: What does it mean for Consumer Medicine?
- What are the implication of shifting site of care for healthcare product manufacturers (both Rx and OTC)
- How does health and wellness fit into consumer priorities during an economic downturn. Implications for HC product manufacturers?
- Does the shifting public policy environment have interesting implications for prevention products and services?
- Who is the “US Health Consumer” since it’s not homogenous and important that everyone understand the differences on attitudes, behaviors and unmet needs of the six discreet segments.
Paul H. Keckley, PhD
Executive Director, Deloitte Center for Health Solutions
Deloitte LLP
|
| |
|
| 12:00-12:45 pm |
The Serial Entrepreneur: Looking Back, Looking Ahead
J. Andy Corley is corporate vice president and global president, Surgical Products, for Bausch & Lomb. In 1998, Andy co-founded eyeonics, Inc., which developed a new category of intraocular lens — the accommodating IOL — for use in cataract replacement surgery. He gained FDA approval for innovative crystalens® in 2003, and spearheaded a five-year effort to change CMS policy to allow Medicare beneficiaries to choose presbyopia-correcting IOLs. Eyeonics was acquired by Bausch & Lomb in 2008. Andy has held various executive positions at American Medical Optics and Allergan Pharmaceuticals. He was co-founder of Chiron Ophthalmics, where he played a key role in the introduction of LASIK surgery. Andy is a successful serial entrepreneur who brings a spirit of innovation to both product and organizational development
J. Andy Corley
Corporate Vice President & Global President, Surgical Products
Bausch & Lomb |
| |
|
| 12:45-2:15 pm |
Luncheon with Scott Gottlieb
Top 10 List of Advice for the New Administration: Dr. Gottlieb will discuss potential implications of the Administration’s stimulus and budget activities on the health care sector, with an emphasis on implications for innovation and product development in the consumer medicine space. He will discuss potential shifts in decision-making influence – and financial responsibility – among payers, prescribers, manufacturers, and patients as consumers.
Scott Gottlieb
Former Deputy Commissioner for Medical & Scientific Affairs
US Food and Drug Administration |
| |
|
| 2:15-3:00 pm |
Putting the Platitudes to Work: Lessons from the Front Lines
Translating high-level strategy into implementation can be particularly challenging in Consumer Medicine. Successful entrepreneurs discuss their experiences with specific advice as to how to get things done
- In building a team that balances consumer and healthcare experience
- In integrating consumer insight in to product development
- In working with the channel over time
Moderator:
Cami Samuels
Managing Director
Versant Ventures
Panelists:
|
Ernest Mario
CEO
Capnia
Jeff Nugent
President & CEO
Ventus Medical |
Eric Miller
President
Microfabrica Inc.
Mike Valentino
Former CEO
Adams Respiratory/ Novartis
|
| |
|
| 3:00-3:30 pm |
Concept Testing…Insights Focus Groups Can’t Provide
How do you evaluate consumer receptiveness when bringing a wholly new product concept to market?
Mike Waite
Vice President, Enterprise Products and Marketing
MarketTools |
| |
|
| 3:30-4:15 pm |
Networking Reception |
| |
Hosted by: |
|
|
| |
|
| 4:15-5:00 pm |
Emerging Influencers:
Who are the new players in the shifting Healthcare landscape and what does it mean for Consumer Medicine players?
In the healthcare landscape there are emerging and evolving influencers who have a fundamentally different relationship with patients and consumers. They also have a different set of objectives. What are the implications for Consumer Medicine?
- What problem is your company trying to solve and what is your company's goal?
- What is the growth potential in your market?
Why are new influencers emerging now and what are some potential trends?
- How can Consumer Medical product manufacturers effectively partner with the influencers?
- How is the partnership with influencers different from the traditional manufacturer-physician relationship or Direct-To-Consumer (DTC) marketing?
Moderator:
Ted Janus
Private Investor
Panelists:
|
Diane Miles
President & CEO
Perricone MD
Kyle Rolfing
CEO
Redbrick Health |
Mark Murrison
Strategic Business Development
MDVIP
Vance Vanier
Chief Medical Officer
Navigenics |
| |
|
| 5:00-6:00 pm |
The Innovator’s Prescription: A Disruptive Solution for Health Care
A prescription for what ails health care – how Disruptive Innovation will change the roles of providers and consumers in creating a more affordable, accessible and effective system for all.
Jason Hwang, MD, MBA
Executive Director, Healthcare
Innosight Institute |
| |
|
| 6:00-6:10 pm |
Wrap-Up |
| |
|
| 6:10-7:15 pm |
Cocktail Reception
|
| |
Hosted by:  |
| 7:15-9:00 pm |
Gala Dinner with America’s 1st Master Sommelier
Eddie Osterland
|
| |
Hosted by:  |
| 9:00-11:00 pm |
Casino Party |
| |
Hosted by:  |
and 